A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY

WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS.

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.

MEDSIR favors a collaborative approach for clinical development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.

TOGETHER WE CAN BUILD A BRIGHTER FUTURE

THINK TANK MEETING 2022

We had the pleasure to host a Think Tank Meeting in Barcelona: 5 Key Opinion Leaders (KOLs) in breast cancer field and over 25 breast cancer oncologists from emerging markets of LATAM, Asia and AfME, were invited to a 3-day-dynamic, with the aim of establishing new connections with their colleagues worldwide while learning how to design innovative and strategic trials.

If you’re interested in taking part of the next Think Tank Meeting or would like to sponsor it, don’t hesitate to contact us!

Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.